- Report
- December 2024
- 200 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- September 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2024
- 180 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 135 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- June 2025
- 196 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 374 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 341 Pages
Global
From €3628EUR$4,050USD£3,092GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more